Effect of receptor for hyaluronan-mediated motility inhibition on radiosensitivity of lung adenocarcinoma A549 cells

BACKGROUND: Receptor for hyaluronan-mediated motility (RHAMM), one of the major hyaluronic acid (HA) receptors, is upregulated in several forms of cancer and is a poor prognostic factor for non-small cell lung cancer (NSCLC) adenocarcinoma. RHAMM is also a potential therapeutic target for inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Chunzi, Liu, Shilong, Wang, Yanli, Cha, Geqi, Xu, Xiangying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798256/
https://www.ncbi.nlm.nih.gov/pubmed/35116773
http://dx.doi.org/10.21037/tcr.2019.02.03

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798256/
https://www.ncbi.nlm.nih.gov/pubmed/35116773
http://dx.doi.org/10.21037/tcr.2019.02.03

Ejemplares similares